JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EGIO
6926
DELISTED
Edgio, Inc. Common Stock
EGIO
| $19 | ﹤0.01% |
2
-1,598
| -100% | -$15.3K |
2016 Q4
29 quarters
|
|
|
AKLI
6927
DELISTED
Akili Inc
AKLI
| $19 | ﹤0.01% |
67
+29
| +76% | +$9 |
2023 Q3
2 quarters
|
|
|
CTHR
6928
DELISTED
Charles & Colvard Ltd
CTHR
| $19 | ﹤0.01% |
6
+2
| +50% | +$8 |
2023 Q3
2 quarters
|
|
|
NVOS
6929
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
| $19 | ﹤0.01% |
40
+14
| +54% | +$9 |
2023 Q4
1 quarter
|
|
6930
ProShares Short Real Estate
REK
$12.6M
| $18 | ﹤0.01% |
1
-5
| -83% | -$95 |
2022 Q2
7 quarters
|
|
6931
Haoxi Health Technology Ltd
HAO
$989K
| – | – |
0
| – | – |
2024 Q1
0 quarters
|
|
|
XAGE
6932
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
| – | – |
0
| – | – |
2023 Q4
1 quarter
|
|
|
MMAT
6933
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $18 | ﹤0.01% |
6
+5
| +500% | +$20 |
2021 Q2
11 quarters
|
|
6934
DarioHealth
DRIO
$63.3M
| $17 | ﹤0.01% |
1
| – | – |
2021 Q2
11 quarters
|
|
|
ELSE
6935
DELISTED
Electro-Sensors
ELSE
| $17 | ﹤0.01% |
4
+2
| +100% | +$8 |
2023 Q3
2 quarters
|
|
6936
Intelligent Bio Solutions
INBS
$5.51M
| – | – |
0
| – | – |
2024 Q1
0 quarters
|
|
6937
iPower
IPW
$1.31M
| – | – |
0
| – | – |
2023 Q3
2 quarters
|
|
6938
Solitario Resources
XPL
$54.3M
| $17 | ﹤0.01% |
29
-84
| -74% | -$45 |
2023 Q3
2 quarters
|
|
6939
Borealis Foods
BRLS
$26M
| $17 | ﹤0.01% |
+3
| New | +$27 |
2024 Q1
0 quarters
|
|
|
RGF
6940
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| $17 | ﹤0.01% |
4
-250
| -98% | -$3.17K |
2023 Q3
2 quarters
|
|
|
RBT
6941
DELISTED
Rubicon Technologies, Inc.
RBT
| $17 | ﹤0.01% |
+42
| New | +$41 |
2024 Q1
0 quarters
|
|
6942
DSS Inc
DSS
$6.41M
| $16 | ﹤0.01% |
9
+2
| +29% | +$4 |
2023 Q3
2 quarters
|
|
|
NCSM
6943
DELISTED
NCS Multistage Holdings
NCSM
| $16 | ﹤0.01% |
1
| – | – |
2023 Q3
2 quarters
|
|
6944
SIFCO Industries
SIF
$148M
| $16 | ﹤0.01% |
5
+1
| +25% | +$3 |
2023 Q3
2 quarters
|
|
|
SOBR
6945
DELISTED
SOBR SAFE INC
SOBR
| – | – |
0
| – | – |
2023 Q4
1 quarter
|
|
6946
Planet Image International
YIBO
$62.2M
| $16 | ﹤0.01% |
+5
| New | +$13 |
2024 Q1
0 quarters
|
|
|
SHPW
6947
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
| $16 | ﹤0.01% |
8
+3
| +60% | +$6 |
2023 Q3
2 quarters
|
|
|
AXDX
6948
DELISTED
Accelerate Diagnostics
AXDX
| $15 | ﹤0.01% |
15
+4
| +36% | +$6 |
2017 Q4
25 quarters
|
|
6949
Genprex
GNPX
$2.16M
| – | – |
0
| – | – |
2021 Q2
11 quarters
|
|
6950
HCW Biologics
HCWB
$3.76M
| – | – |
0
| – | – |
2023 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.